Nanosizing techniques for improving bioavailability of drugs.

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery
• Materials Science

Background:

• Poor solubility of Active Pharmaceutical Ingredients (APIs) is a significant hurdle in drug development, leading to formulation difficulties and reduced bioavailability.
• Nanosizing techniques, which reduce drug particle size to the sub-micron range, have emerged as a key strategy to overcome poor solubility.
• The success of nanocrystal technology is highlighted by six FDA-approved drugs demonstrating improved bioavailability over conventional forms.

Purpose of the Study:

• To review various nanosizing methods for preparing drug nanocrystals.
• To discuss the impact of nanosizing on drug dissolution rate and bioavailability.
• To compare top-down and bottom-up approaches for nanocrystal fabrication.

Main Methods:

• Discussion of top-down techniques for nanocrystal preparation, noting their successful application at lab and commercial scales.
• Exploration of bottom-up approaches, which offer simple methods for narrow-sized nanocrystal distribution, though not yet commercialized.
• Consideration of hybrid approaches combining top-down and bottom-up methods for nanoparticle production.

Main Results:

• Nanosizing significantly increases drug surface area, leading to enhanced dissolution rates.
• Drug nanocrystals demonstrate markedly improved bioavailability compared to conventional formulations.
• Both top-down and bottom-up methods, as well as combined approaches, are effective in producing drug nanoparticles.

Conclusions:

• Nanosizing is a critical strategy for improving the bioavailability of poorly soluble drugs.
• Top-down methods are established for large-scale production, while bottom-up methods show promise for controlled nanocrystal synthesis.
• Further research into nanosizing techniques is essential for advancing pharmaceutical formulation and drug delivery.